# AMTAGVI

NDC: 73776-001
Generic name: lifileucel
Labeler / Manufacturer: Iovance Biotherapeutics Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20240216

FDA application: BLA125773

## Active ingredients

- LIFILEUCEL: 72000000000 1/500mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73776-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73776-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4121bd3f-2d6e-3bdd-e063-6294a90a3088